J&J to Add Drug Discovery, Early Research to Actelion

Johnson & Johnson plans to build the soon-to-be acquired Actelion business into a drug discovery-to-commercialization organization dedicated to pulmonary arterial hypertension.

from WSJ.com: US Business http://ift.tt/2sCee0x
via IFTTT